Report Library
View More
Dry Eye Syndrome KOL Interview - UK
April 28, 2026
Dry Eye Syndrome KOL Interview - US...
April 24, 2026
2025 Deal-making Roundup
April 20, 2026
Hidradenitis Suppurativa KOL Interv...
April 20, 2026
Hidradenitis Suppurativa KOL Interv...
April 20, 2026
Hidradenitis Suppurativa KOL Interv...
April 16, 2026
Idiopathic Pulmonary Fibrosis KOL I...
April 15, 2026
Idiopathic Pulmonary Fibrosis KOL I...
April 14, 2026
Idiopathic Pulmonary Fibrosis KOL I...
April 13, 2026
Hidradenitis Suppurativa KOL Interv...
April 10, 2026
Datamonitor Healthcare CNS Disease ...
April 7, 2026
Acute Lymphoblastic Leukemia KOL In...
April 1, 2026
Acute Lymphoblastic Leukemia KOL In...
March 31, 2026
Acute Lymphoblastic Leukemia KOL In...
March 31, 2026
Acute Lymphoblastic Leukemia KOL In...
March 30, 2026
Acute Lymphoblastic Leukemia KOL In...
March 30, 2026
Datamonitor Healthcare I&I Disease ...
March 30, 2026
Datamonitor Healthcare CV&Met: Veno...
March 10, 2026
Datamonitor Healthcare CV&Met: Atri...
March 10, 2026
Datamonitor Healthcare Oncology: Sm...
March 10, 2026
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 4/27/26 | Compass Therapeutics (CMPX) | tovecimig for Biliary Tract Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/23/26 | Novo Nordisk (NVO) | Rybelsus for Diabetes Mellitus, Type II | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/23/26 | AbbVie (ABBV) | Trenibote for Wrinkles | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/22/26 | Anthos Therapeutics | abelacimab for Venous Thromboembolism (VTE) | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/21/26 | CytoDyn (CYDY) | Vyrologix for Colorectal Cancer (CRC) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |